TOVX – theriva biologics, inc. (US:NASDAQ)
Stock Stats
News
Theriva™ Biologics Announces Positive End-of-Phase 2 Meeting with U.S. FDA Regarding the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma
Theriva™ Biologics Reports Full-Year 2025 Operational Highlights and Financial Results [Yahoo! Finance]
Theriva™ Biologics Reports Full-Year 2025 Operational Highlights and Financial Results
Theriva™ Biologics Licenses SYN-020 to Rasayana Therapeutics for Multiple Indications
Theriva™ Biologics Announces Upcoming Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at APAO 2026
Form 8-K Theriva Biologics, Inc. For: Mar 23
Form DEF 14A Theriva Biologics, Inc. For: Apr 09
Form 10-K Theriva Biologics, Inc. For: Dec 31
Form 8-K Theriva Biologics, Inc. For: Mar 12
Form PRE 14A Theriva Biologics, Inc. For: Mar 04
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.